Xeltis announced the official start of the European commercialization of aXess vascular access device for patients requiring hemod ...

Fluidx Medical Technology, Inc. announced results from a pivotal clinical trial evaluating the company’s GPX embolic device.

The Society for Cardiovascular Angiography and Interventions (SCAI) announced that a multisociety expert consensus statement ...

HistoSonics announced that it has received approval in Europe for its Edison system, enabling the commercialization of the ...

Delcath Systems, Inc., an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announ ...

Vesalio announced the appointment of Greg Cook as Chief Commercial Officer, responsible for leading the company’s commercial ...

Penumbra, Inc. announced the initiation of its FORWARD study, which will collect safety and efficacy data on mechanical ...

Egg Medical, a developer of enhanced radiation protection devices (ERPDs) for interventional procedures, announced the launch ...

Stereotaxis announced that it has completed its previously announced acquisition of Robocath, a Rouen, France-based developer ...

Gore & Associates announced that the FDA approved updated labeling for the Gore Excluder abdominal aortic aneurysm (AAA) ...

Shape Memory Medical Inc., developer of a commercially available volume-expanding shape memory polymer for endovascular embolizatio ...

Glucagon‐like peptide‐1 receptor agonists (GLP-1 RAs) were shown to be associated with lower risks of death, hospitalization, ...